Related Experiment Video
Updated: Aug 12, 2026
06:40
Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
Rp-cAMPS has no effect on adenosine A1 receptors in guinea-pig cardiomyocytes
1Imperial College of Science Technology and Medicine, National Heart and Lung Institute, London, UK. d.adamson@ic.ac.uk
Basic Research in Cardiology
|May 29, 2000
Summary
Rp-cAMPS reliably investigates cyclic AMP-dependent systems in cardiac myocytes. This protein kinase A inhibitor does not affect cell contraction via adenosine A1 receptors, confirming its specificity.
Area of Science:
- Cardiovascular Physiology
- Molecular Pharmacology
- Cell Signaling
Background:
- Rp-cAMPS is a widely used inhibitor of protein kinase A (PKA) for studying cyclic AMP (cAMP)-dependent pathways.
- Previous research suggested Rp-cAMPS might interact with adenosine receptors, potentially confounding its use in cAMP research.
Purpose of the Study:
- To investigate whether Rp-cAMPS affects adenosine A1 receptors in guinea-pig ventricular myocytes.
- To confirm the reliability of Rp-cAMPS as a specific PKA inhibitor in cardiac research.
Main Methods:
- Guinea-pig ventricular myocytes were treated with Rp-cAMPS.
- The isoprenaline-induced contractile response was measured.
- Experiments were repeated in the presence of DCPCX, an adenosine A1 receptor antagonist.
Main Results:
- Rp-cAMPS significantly reduced the isoprenaline-induced response in myocytes.
- The presence of DCPCX did not alter the inhibitory effect of Rp-cAMPS.
- This indicates Rp-cAMPS does not act through adenosine A1 receptors in this context.
Conclusions:
- Rp-cAMPS does not exert its effects on guinea-pig ventricular myocyte contraction via adenosine A1 receptors.
- Rp-cAMPS can be reliably used as a specific inhibitor for studying cAMP-dependent systems in isolated cardiac myocytes.
- This finding supports the use of Rp-cAMPS in cardiovascular research without concerns of adenosine receptor cross-reactivity.
Related Concept Videos
01:21G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...